Figure 1: Ion transporters involved in regulation of cytosolic Cl-environments and roles of cytosolic Cl- in cell function. Na+/H+ exchanger (NHE) has no direct contribution to intracellular Cl- environments, since NHE directly participates in Na+ uptake coupling with H+ extrusion. However, application of an inhibitor of NHE, EIPA, lowers the cytosolic Cl- concentration ([Cl-]c) without any effect on cytosolic pH (pHc) [31]. The EIPA-caused lowered [Cl-]c would be due to activation of Na+-driven Cl-/HCO3 - exchanger (NDCBE) compensating the EIPA-caused acute lowered pHc [31]. For example, in cancer cells mitochondria function is low, leading to low production of CO2. This means that contents of H+ and HCO3 - induced by CO2 from mitochondria are low in cytosolic space of cancer cells. On the one hand, cancer cells produce a lot of H+ via glycolysis, being converted to CO2 and H2O with HCO3 - a carbonic anhydrase-mediated process, resulting in lowered HCO3 - in cytosolic space. Taken together, the amount of HCO3 - in cytosolic space of cancer cells is much lower than that in normal cells. Thus, activation of ion transporters taking HCO3 - up into the cytosolic space such as NDCBE, which extrudes cytosolic Cl- using electrochemical gradient of Na+, in cancer cells with a low HCO3 - condition is much effective in lowering [Cl-]c than normal cells. Namely, inhibition of NHE and activation of NDCBE would effectively decrease [Cl-]c, under a condition with low mitochondria function occurring in cancer cells. This leads cancer cells to G0/G1 arrest via a MPKs-p21-Rb pathway and autophagy dysfunction via elevation of intra-lysosomal pH. Based on the information described above, some drugs modifying activity of ion transporters involved in regulation of cytosolic Cl- environments would be useful for anticancer therapies.
AE, Cl-/HCO3 - exchanger; ClC-7, 2Cl-/1H+ exchange; MPKs, mitogen-activated protein kinases; NBC, Na+-HCO3 - cotransporter; NDCBE, Na+-driven Cl-/HCO3 - exchanger; NHE, Na+/H+ exchanger; NKCC, Na+-K+-2Cl- cotransporter; Rb, retinoblastoma protein; V-ATPase, V-type H+-ATPase.